A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry

摘要

BACKGROUND First-in-man studies of leadless pacemakers have demonstrated high rates of implant success, and safety and efficacy objectives were achieved. Outside of the investigational setting, there are concerns, particularly over cardiac effusion and perforation, device dislodgement, infection, telemetry, and battery issues. OBJECTIVE The acute performance of the Micra transcatheter pacemaker from a worldwide Post-Approval Registry is reported.